Tandem Diabetes Care Inc
TNDM21.840USD
+0.370+1.72%
Close 11/25, 16:00（ET）Quotes delayed by 15 min
1.48BMarket Cap
LossP/E TTM
More Details of Tandem Diabetes Care Inc Company
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Tandem Diabetes Care Inc Info
Ticker SymbolTNDM
Company nameTandem Diabetes Care Inc
IPO dateNov 13, 2013
CEOMr. John F. Sheridan
Number of employees2650
Security typeOrdinary Share
Fiscal year-endNov 13
Address12400 High Bluff Drive
CitySAN DIEGO
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code92130
Phone18583666900
Websitehttps://www.tandemdiabetes.com/
Ticker SymbolTNDM
IPO dateNov 13, 2013
CEOMr. John F. Sheridan
Company Executives of Tandem Diabetes Care Inc
Name
Name/Position
Position
Shareholding
Change
Mr. John F. Sheridan
Mr. John F. Sheridan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
117.60K
+5.03%
Ms. Leigh A. Vosseller
Ms. Leigh A. Vosseller
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
49.51K
+4.05%
Ms. Susan M. Morrison
Ms. Susan M. Morrison
Executive Vice President, Chief Administrative Officer
Executive Vice President, Chief Administrative Officer
40.92K
+4.75%
Mr. Mark David Novara
Mr. Mark David Novara
Executive Vice President and Chief Commercial Officer
Executive Vice President and Chief Commercial Officer
32.38K
+0.11%
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
28.36K
+18.30%
Mr. Rick Carpenter
Mr. Rick Carpenter
Chief Technical Officer
Chief Technical Officer
24.05K
+6.59%
Mr. Jean-Claude (JC) Kyrillos
Mr. Jean-Claude (JC) Kyrillos
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
22.54K
+0.71%
Dr. Kathleen McGroddy-Goetz, Ph.D.
Dr. Kathleen McGroddy-Goetz, Ph.D.
Independent Director
Independent Director
17.85K
+32.58%
Ms. Peyton R. Howell
Ms. Peyton R. Howell
Independent Director
Independent Director
--
--
Mr. Joao Paulo Malagueira
Mr. Joao Paulo Malagueira
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. John F. Sheridan
Mr. John F. Sheridan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
117.60K
+5.03%
Ms. Leigh A. Vosseller
Ms. Leigh A. Vosseller
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
49.51K
+4.05%
Ms. Susan M. Morrison
Ms. Susan M. Morrison
Executive Vice President, Chief Administrative Officer
Executive Vice President, Chief Administrative Officer
40.92K
+4.75%
Mr. Mark David Novara
Mr. Mark David Novara
Executive Vice President and Chief Commercial Officer
Executive Vice President and Chief Commercial Officer
32.38K
+0.11%
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
28.36K
+18.30%
Mr. Rick Carpenter
Mr. Rick Carpenter
Chief Technical Officer
Chief Technical Officer
24.05K
+6.59%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Pump
223.74M
46.48%
Supplies and other
128.81M
26.76%
Supplies and other - Domestic
84.74M
17.60%
Supplies and other-International
44.06M
9.15%
Deferral for Tandem Choice program-Domestic
0.00
0.00%
By RegionUSD
Name
Revenue
Proportion
Domestic
85.47M
17.76%
International
26.40M
5.49%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Pump
223.74M
46.48%
Supplies and other
128.81M
26.76%
Supplies and other - Domestic
84.74M
17.60%
Supplies and other-International
44.06M
9.15%
Deferral for Tandem Choice program-Domestic
0.00
0.00%
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.97%
The Vanguard Group, Inc.
10.40%
Sessa Capital
7.37%
ArrowMark Colorado Holdings, LLC
5.44%
GW&K Investment Management, LLC
4.01%
Other
57.80%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.97%
The Vanguard Group, Inc.
10.40%
Sessa Capital
7.37%
ArrowMark Colorado Holdings, LLC
5.44%
GW&K Investment Management, LLC
4.01%
Other
57.80%
Shareholder Types
Shareholders
Proportion
Investment Advisor
55.96%
Investment Advisor/Hedge Fund
31.27%
Hedge Fund
20.88%
Research Firm
5.08%
Pension Fund
1.32%
Individual Investor
1.08%
Bank and Trust
0.93%
Venture Capital
0.11%
Family Office
0.07%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
659
81.42M
120.08%
-12.14M
2025Q2
684
76.82M
113.72%
-10.68M
2025Q1
717
75.41M
113.22%
-13.00M
2024Q4
729
74.63M
112.27%
-13.07M
2024Q3
730
75.54M
115.38%
-14.87M
2024Q2
754
76.14M
117.84%
-16.88M
2024Q1
762
76.49M
116.55%
-10.19M
2023Q4
800
72.80M
111.65%
-12.99M
2023Q3
790
71.79M
110.32%
-10.32M
2023Q2
793
70.34M
108.90%
-11.97M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
9.60M
14.2%
-159.92K
-1.64%
Jun 30, 2025
The Vanguard Group, Inc.
7.36M
10.89%
+77.66K
+1.07%
Jun 30, 2025
Sessa Capital
5.00M
7.4%
+533.69K
+11.95%
Jun 30, 2025
ArrowMark Colorado Holdings, LLC
2.70M
4%
-16.78K
-0.62%
Jun 30, 2025
GW&K Investment Management, LLC
2.89M
4.28%
+26.14K
+0.91%
Jun 30, 2025
State Street Investment Management (US)
2.65M
3.92%
-41.85K
-1.56%
Jun 30, 2025
Hood River Capital Management LLC
2.56M
3.8%
+252.93K
+10.94%
Jun 30, 2025
Paradice Investment Management LLC
1.77M
2.62%
+117.27K
+7.11%
Jun 30, 2025
Two Sigma Investments, LP
2.12M
3.14%
+799.78K
+60.54%
Jun 30, 2025
View more
Related ETFs
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
SPDR S&P Health Care Equipment ETF
1.61%
Fidelity Digital Health ETF
1.15%
Global X HealthTech ETF
0.72%
Invesco S&P SmallCap Health Care ETF
0.52%
Invesco NASDAQ Future Gen 200 ETF
0.47%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.33%
Langar Global HealthTech ETF
0.19%
Inspire Small/Mid Cap ESG ETF
0.12%
Fidelity Enhanced Small Cap ETF
0.12%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.11%
View more
SPDR S&P Health Care Equipment ETF
Proportion1.61%
Fidelity Digital Health ETF
Proportion1.15%
Global X HealthTech ETF
Proportion0.72%
Invesco S&P SmallCap Health Care ETF
Proportion0.52%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.47%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion0.33%
Langar Global HealthTech ETF
Proportion0.19%
Inspire Small/Mid Cap ESG ETF
Proportion0.12%
Fidelity Enhanced Small Cap ETF
Proportion0.12%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proportion0.11%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Tandem Diabetes Care Inc?
The top five shareholders of Tandem Diabetes Care Inc are:
BlackRock Institutional Trust Company, N.A. holds 9.60M shares, accounting for 14.20% of the total shares.
The Vanguard Group, Inc. holds 7.36M shares, accounting for 10.89% of the total shares.
Sessa Capital holds 5.00M shares, accounting for 7.40% of the total shares.
ArrowMark Colorado Holdings, LLC holds 2.70M shares, accounting for 4.00% of the total shares.
GW&K Investment Management, LLC holds 2.89M shares, accounting for 4.28% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 9.60M shares, accounting for 14.20% of the total shares.
The Vanguard Group, Inc. holds 7.36M shares, accounting for 10.89% of the total shares.
Sessa Capital holds 5.00M shares, accounting for 7.40% of the total shares.
ArrowMark Colorado Holdings, LLC holds 2.70M shares, accounting for 4.00% of the total shares.
GW&K Investment Management, LLC holds 2.89M shares, accounting for 4.28% of the total shares.
What are the top three shareholder types of Tandem Diabetes Care Inc?
The top three shareholder types of Tandem Diabetes Care Inc are:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Sessa Capital
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Sessa Capital
How many institutions hold shares of Tandem Diabetes Care Inc (TNDM)?
As of 2025Q3, 659 institutions hold shares of Tandem Diabetes Care Inc, with a combined market value of approximately 81.42M, accounting for 120.08% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 6.37%.
What is the biggest source of revenue for Tandem Diabetes Care Inc?
In FY2025Q2, the Pump business generated the highest revenue for Tandem Diabetes Care Inc, amounting to 223.74M and accounting for 46.48% of total revenue.
